Works matching IS 11745878 AND DT 2021 AND VI 23 AND IP 5
Results: 9
Targeted Therapy in Pediatric AML: An Evolving Landscape.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 485, doi. 10.1007/s40272-021-00467-x
- By:
- Publication type:
- Article
Managing Patient Pressure to Prescribe Antibiotics in the Clinic.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 437, doi. 10.1007/s40272-021-00466-y
- By:
- Publication type:
- Article
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 465, doi. 10.1007/s40272-021-00465-z
- By:
- Publication type:
- Article
Management of IgA Vasculitis with Nephritis.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 425, doi. 10.1007/s40272-021-00464-0
- By:
- Publication type:
- Article
Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 457, doi. 10.1007/s40272-021-00463-1
- By:
- Publication type:
- Article
Pediatric Urologic Surgery: Reducing Opioid Use.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 417, doi. 10.1007/s40272-021-00462-2
- By:
- Publication type:
- Article
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 515, doi. 10.1007/s40272-021-00459-x
- By:
- Publication type:
- Article
Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 445, doi. 10.1007/s40272-021-00461-3
- By:
- Publication type:
- Article
Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 499, doi. 10.1007/s40272-021-00460-4
- By:
- Publication type:
- Article